Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

MorphoSys and Absynth collaborate on research into infectious disease

Sep. 7, 2010

Stallergenes and Shionogi partner on two immunotherapy tablets

Sep. 7, 2010

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Sep. 6, 2010

Ipsen gains rights to fipamezole outside of North America and Japan

Sep. 3, 2010

iBio, Fraunhofer and GE Healthcare to partner for iBioLaunch platform

Sep. 3, 2010

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

MorphoSys and Absynth partner for MRSA treatments

Sep. 3, 2010

HUYA and Sun Yat-sen University to develop novel drugs in China

Sep. 2, 2010

Ono receives exclusive rights in Japan to salirasib

Sep. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...